Visterra Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Visterra is a clinical-stage biotechnology company focused on developing antibody-based therapies for kidney disease and other hard-to-treat conditions. Its proprietary platform supports the creation of precision antibodies that target specific disease pathways and modulate disease activity. The company is based in Waltham, Massachusetts, and is a wholly owned subsidiary of Otsuka America, Inc. Operating in the biotechnology research sector, Visterra seeks to advance a portfolio of therapies intended for patients with kidney disease and other challenging conditions. In December 2024, Scailyte AG announced a biomarker-discovery collaboration with Visterra.